<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">FLUCYTOSINE</span><br/>(floo-sye'toe-seen)<br/><span class="topboxtradename">Ancobon, </span><span class="topboxtradename">Ancotil <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">5-FC, </span><span class="topboxtradename">5-Fluorocytosine<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">antifungal</span><br/><b>Prototype: </b>Fluconazole<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Ineffective for cancerous tumors possibly because it does not enter mammalian cells. Selectively penetrates fungal cell and
         is converted to fluorouracil, an antimetabolite believed to be responsible for antifungal activity.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Has antifungal activity against <i>Cryptococcus</i> and <i>Candida</i> as well as <i>Chromomycosis.</i>
</p>
<h1><a name="uses">Uses</a></h1>
<p>Alone or in combination with amphotericin B for serious systemic infections caused by susceptible strains of <i>Cryptococcus</i> and <i>Candida</i> species.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p> <i>Chromomycosis.</i>
</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Safety during pregnancy (category C) or lactation is not established.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Extreme caution in impaired kidney function; bone marrow depression, hematologic disorders, patients being treated with or
         having received radiation or bone marrow depressant drugs.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Fungal Infection</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 50150 mg/kg/d divided q6h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 50 kg, 1.54.5 g/m<sup>2</sup>/d divided q6h; &gt;<i>50 kg,</i> 50150 mg/kg/d divided q6h<br/><span class="rdage">Neonate:</span> <span class="rdroute">PO</span> 50100 mg/kg/d in 12 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give lower dosages with longer dosage intervals in patients with serum creatinine of 1.7 mg/dL or higher. Check with physician.</li>
<li>Give capsules a few at a time over 15 min to decrease incidence and severity of nausea and vomiting.</li>
<li>Store in light-resistant containers at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Confusion, hallucinations, headache, sedation, vertigo. <span class="typehead">GI:</span> Nausea, vomiting, diarrhea, abdominal bloating, enterocolitis. <span class="typehead">Hematologic:</span> Hypoplasia of bone marrow: anemia, leukopenia, thrombocytopenia, <span class="speceff-life">agranulocytosis</span>, eosinophilia. <span class="typehead">Skin:</span> Rash. <span class="typehead">Metabolic:</span> Elevated levels of serum alkaline phosphatase, AST, ALT, BUN, serum creatinine. <span class="typehead">GI:</span> Hepatomegaly, hepatitis. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>False elevations of <span class="alt">serum creatinine</span> can occur with <span class="alt">Ektachem analyzer.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Amphotericin B</b> produces additive or synergistic effects and can increase flucytosine toxicity by inhibiting its renal clearance. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 2 h. <span class="typehead">Distribution:</span> Widely distributed in body tissues including aqueous humor and CSF; crosses placenta. <span class="typehead">Metabolism:</span> Minimally metabolized. <span class="typehead">Elimination:</span> 7590% excreted in urine unchanged. <span class="typehead">Half-Life:</span> 36 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>C&amp;S tests should be performed before initiation of therapy and at weekly intervals during therapy. Organism resistance has
            been reported.
         </li>
<li>Lab tests: Obtain baseline hematology, kidney and liver function on all patients before and at frequent intervals during therapy.
            Twice weekly leukocyte and differential counts with WBC with differential and platelet counts are recommended.
         </li>
<li>Do frequent assays of blood drug level, especially in patients with impaired kidney function to determine adequacy of drug
            excretion (therapeutic range: 25120 mg/mL).
         </li>
<li>Monitor I&amp;O. Report change in I&amp;O ratio or pattern. Because most of drug is eliminated unchanged by kidneys, compromised function
            can lead to drug accumulation.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report fever, sore mouth or throat, and unusual bleeding or bruising tendency to physician.</li>
<li>Be aware that the general duration of therapy is 46 wk, but it may continue for several months.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>